Patents by Inventor Joachim Schultz

Joachim Schultz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Identifying PDE11 Modulators
    Publication number: 20090298108
    Abstract: The invention relates to a novel GAFA domain-containing polypeptide, to the GAFA domain of a human phosphodiesterase 11 (PDE11) and to the adenylate cyclase catalytic domain. The use of said polypeptide in a method for identifying PDE-11 modulators is also disclosed.
    Type: Application
    Filed: May 18, 2005
    Publication date: December 3, 2009
    Inventors: Joachim Schultz, Marco Gross-Langenhoff
  • Method for Identifying PDE5-Modulators
    Publication number: 20090087871
    Abstract: The invention relates to a novel polypeptide containing the GAFA-domain and GAFB-domain of a human phosphodiesterase 5 (PDE5) and the catalytic domain of an adenylate cyclase, and to the use of this polypeptide in a method for identifying PDE5-modulators.
    Type: Application
    Filed: May 18, 2005
    Publication date: April 2, 2009
    Applicant: Atlanta Pharma AG
    Inventors: Tobias Kanacher, Juergen Linder, Joachim Schultz
  • Ion channel
    Publication number: 20050124791
    Abstract: The invention relates to a protein, which comprises an adenylate cyclase domain in addition to an ion channel domain. The ion channel domain is preferably a potassium ion channel domain, which is sensitive to voltage. In addition, the protein has a C-terminal protein-protein interaction domain. The invention also relates to nucleotide sequences, which code for proteins of this type.
    Type: Application
    Filed: November 8, 2002
    Publication date: June 9, 2005
    Inventors: Helge Volkel, Joachim Schultz, Jurgen Linder
  • Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis
    Publication number: 20050048603
    Abstract: A method for expression of membrane proteins is provided, wherein at least a portion of a nucleotide sequence coding to the membrane protein is fused to at least a portion of a nucleotide sequence coding for an adenylyl cyclase of Mycobacterium tuberculosis or a sequence at least about 70% identical to said sequence of Mycobacterium tuberculosis. In a second step the fused nucleotide sequence is introduced into an organism and/or a living cell. Another aspect of the invention is a method for searching active agents, which interact directly with adenylyl cyclases.
    Type: Application
    Filed: May 14, 2002
    Publication date: March 3, 2005
    Inventors: Helge Volkel, Joachim Schultz, Jurgen Linder
  • Cathepsin L, its prepro form and the corresponding propeptide from ciliates
    Patent number: 6733995
    Abstract: The invention relates to the isolation of the prepro form of cathepsin L, of its leader sequence, of cathepsin L and of the affiliated propeptide from ciliates, in particular Paramecium, to the use of these peptides and to a process for preparing cathepsin L from ciliates.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: May 11, 2004
    Assignee: Nutrinova Nutrition Specialties & Food Ingredients GmbH
    Inventors: Thomas Kiy, Joachim Schultz
  • Cathepsin L, its prepro form and the corresponding propeptide from ciliates
    Publication number: 20020192795
    Abstract: The invention relates to the isolation of the prepro form of cathepsin L, of its leader sequence, of cathepsin L and of the affiliated propeptide from ciliates, in particular Paramecium, to the use of these peptides and to a process for preparing cathepsin L from ciliates.
    Type: Application
    Filed: October 18, 2001
    Publication date: December 19, 2002
    Inventors: Thomas Kiy, Joachim Schultz
  • Cathepsin-L, the pre-proform thereof and the corresponding propeptide from ciliates
    Patent number: 6312935
    Abstract: The invention relates to the isolation of the prepro form of cathepsin L, of its leader sequence, of cathepsin L and of the affiliated propeptide from ciliates, in particular Paramecium, to the use of these peptides and to a process for preparing cathepsin L from ciliates.
    Type: Grant
    Filed: April 13, 1998
    Date of Patent: November 6, 2001
    Assignees: Hoechst Research & Technology, Deutschland GmbH & Co. KG
    Inventors: Thomas Kiy, Joachim Schultz